Stefan Korsatko - Concepedia

Author

Stefan Korsatko

Medical University of Graz

Also Known As

Korsatko, Stefan, S Korsatko, S. Korsatko, Stefan Korsatko

Publications

801

Citations

H-Index

Concepts

All Affiliations

Medical University of Graz Joanneum Research Novo Nordisk (Denmark)University of Graz University of Sheffield

About

Stefan Korsatko is an author at Medical University of Graz specializing in medicine, immunology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	226
2	Engineering	1	1	63
3	Nursing	1	1	15
4	Public Health	1	1	15
5	Biomedical Engineering	1	1	63

Stefan Korsatko

Publications

740

Citations

H-Index

Page 1

	Year	Citations
A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec Stefan Korsatko, Sigrid Deller, Gerd Koehler, Clinical Drug Investigation Pharmaceutical ScienceMedicinePharmacodynamic ProfilesDiabetesInsulin Management	2013	89
Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood Alexandra Homsy, P. D. van der Wal, Werner Doll, Biomicrofluidics FiltrationImmunohematologyEngineeringAnalytical MicrosystemsImmunology	2012	63
Pharmacodynamics of the long‐acting insulin analogues detemir and glargine following single‐doses and under steady‐state conditions in patients with type 1 diabetes Gerd Koehler, Gerlies Treiber, Andrea Wutte, Diabetes Obesity and Metabolism	2013	49
Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling Manfred Bodenlenz, Christian Höfferer, Christoph Magnes, European Journal of Pharmaceutics and Biopharmaceutics Psoriatic PatientsMedicinePsoriatic ArthritisDermal Pk/pdClinical Dermatology	2012	45
Clinical applicability of <scp>dOFM</scp> devices for dermal sampling Manfred Bodenlenz, Birgit Aigner, Christian Dragatin, Skin Research and Technology	2013	45
Steady state is reached within 2–3 days of once‐daily administration of degludec, a basal insulin with an ultralong duration of action Tim Heise, Stefan Korsatko, Leszek Nosek, Journal of Diabetes	2015	44
Counter‐regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo‐controlled, double‐blind, crossover trial Thomas R. Pieber, Sigrid Deller, Stefan Korsatko, Diabetes Obesity and Metabolism	2015	43
Ultra-Long Pharmacokinetic Properties of Insulin Degludec are Comparable in Elderly Subjects and Younger Adults with Type 1 Diabetes Mellitus Stefan Korsatko, Sigrid Deller, Julia K. Mader, Drugs & Aging	2013	36
The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes Martina Brunner, Thomas R. Pieber, Stefan Korsatko, Drugs & Aging	2015	31
Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes Stefan Lindpointner, Stefan Korsatko, Gerd Köhler, Diabetes Care	2009	29

Page 1